| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $267K | +264.0% |
| SG&A Expense | $3.5M | +482.6% |
| Operating Income | -$3.7M | -458.7% |
| Pre-tax Income | -$3.7M | -458.7% |
| Net Income | -$3.7M | -458.7% |
| EPS (Basic) | -$0.34 | -385.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $932K | -31.1% |
| Total Assets | $940K | -30.6% |
| Current Liabilities | $1.1M | +53.6% |
| Total Liabilities | $1.1M | +53.6% |
| Stockholders' Equity | -$140K | -121.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | — |
| Capital Expenditures | $11K | — |
| Investing Cash Flow | -$11K | — |
| Financing Cash Flow | $2.6M | — |
| Free Cash Flow | -$1.8M | — |